Already the go-to drug of choice for millions with type 2 diabetes, metformin might also fight lung cancer if those patients ...

Dr. Bryant Lin, a Stanford University School of Medicine physician and professor, has never smoked, but in early May 2024, he ...

Accompanying these findings is a call for refined treatment strategies that have potential to better outcomes among patients ...

Bevacizumab biosimilars have the potential to expand access and reduce costs without compromising patient outcomes in ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

Patients at the McGill University Health Centre (MUHC) are the first in Canada, and among the first in the world, to test the ...

The phase 3 SKYSCRAPER-01 trial of tiragolumab and atezolizumab in PD-L1-high non–small cell lung cancer did not meet its ...

Lung cancer, the leading cause of cancer deaths worldwide, is primarily linked to smoking, but experts emphasize quitting and ...

The deal suggests Roche sees substantial promise in Poseida’s technology, as the offer is 215% above the biotech’s closing ...

Genentech, a member of the Roche (RHHBY), reported an update on the Phase III SKYSCRAPER-01 study, evaluating tiragolumab combined with ...